The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Kurt A. Jellinger

Institute of Clinical Neurobiology




Name/email consistency: high



  • Institute of Clinical Neurobiology, Vienna, Austria. 1998 - 2012
  • L Boltzmann Institute of Clinical Neurobiology, University of Vienna, PKH/B Bldg - Baumgartner Hoehe 1, A-1140 Vienna, Austria. 1999 - 2008
  • L. Boltzmann Institute of Clinical Neurobiology, Vienna, Institute of Neuropathology, University of Münster School of Medicine, Germany. 2001


  1. Neuropathology and general autopsy findings in nondemented aged subjects. Jellinger, K.A., Attems, J. Clin. Neuropathol. (2012) [Pubmed]
  2. Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease. Jellinger, K. J. Neural. Transm (2012) [Pubmed]
  3. CSF biomarkers in different phenotypes of Parkinson disease. Jellinger, K.A. J. Neural. Transm (2011) [Pubmed]
  4. Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218. Jellinger, K.A. Exp. Neurol. (2011) [Pubmed]
  5. Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration? Jellinger, K.A., Grazer, A., Petrovic, K., Ropele, S., Alpi, G., Kapeller, P., Ströbel, T., Schmidt, R. Acta Neuropathol. (2011) [Pubmed]
  6. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Jellinger, K.A., Lantos, P.L. Acta Neuropathol. (2010) [Pubmed]
  7. Prevalence of dementia disorders in the oldest-old: an autopsy study. Jellinger, K.A., Attems, J. Acta Neuropathol. (2010) [Pubmed]
  8. Prevalence and pathology of vascular dementia in the oldest-old. Jellinger, K.A., Attems, J. J. Alzheimers Dis. (2010) [Pubmed]
  9. Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases. Jellinger, K.A. Neurodegener. Dis (2010) [Pubmed]
  10. Absence of alpha-synuclein pathology in postencephalitic parkinsonism. Jellinger, K.A. Acta Neuropathol. (2009) [Pubmed]
  11. Formation and development of Lewy pathology: a critical update. Jellinger, K.A. J. Neurol. (2009) [Pubmed]
  12. Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Jellinger, K.A. Front. Neurol. Neurosci (2009) [Pubmed]
  13. Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? Jellinger, K.A. Acta Neuropathol. (2009) [Pubmed]
  14. Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Jellinger, K.A. Acta Neuropathol. (2009) [Pubmed]
  15. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Jellinger, K.A. Biochim. Biophys. Acta (2009) [Pubmed]
  16. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Jellinger, K.A. Acta Neuropathol. (2009) [Pubmed]
  17. Rhombencephalosynapsis with and without associated malformations. Jellinger, K.A. Acta Neuropathol. (2009) [Pubmed]
  18. Recent advances in our understanding of neurodegeneration. Jellinger, K.A. J. Neural. Transm (2009) [Pubmed]
  19. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Jellinger, K.A. Neurodegener. Dis (2008) [Pubmed]
  20. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Jellinger, K.A., Attems, J. Acta Neuropathol. (2008) [Pubmed]
  21. Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker? Jellinger, K.A., Janetzky, B., Attems, J., Kienzl, E. J. Cell. Mol. Med. (2008) [Pubmed]
  22. Cerebral amyloid angiopathy in Lewy body disease. Jellinger, K.A., Attems, J. J. Neural. Transm (2008) [Pubmed]
  23. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Jellinger, K.A. Neurodegener. Dis (2008) [Pubmed]
  24. In memoriam: Franz Seitelberger (1916-2007). Jellinger, K.A. Acta Neuropathol. (2008) [Pubmed]
  25. Morphologic diagnosis of "vascular dementia" - a critical update. Jellinger, K.A. J. Neurol. Sci. (2008) [Pubmed]
  26. The pathology of "vascular dementia": a critical update. Jellinger, K.A. J. Alzheimers Dis. (2008) [Pubmed]
  27. A critical reappraisal of current staging of Lewy-related pathology in human brain. Jellinger, K.A. Acta Neuropathol. (2008) [Pubmed]
  28. Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. Jellinger, K.A., Lauda, F., Attems, J. Eur. J. Neurol. (2007) [Pubmed]
  29. Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study. Jellinger, K.A. J. Neural Transm. Suppl. (2007) [Pubmed]
  30. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Jellinger, K.A., Attems, J. Acta Neuropathol. (2007) [Pubmed]
  31. The enigma of vascular cognitive disorder and vascular dementia. Jellinger, K.A. Acta Neuropathol. (2007) [Pubmed]
  32. Neuropathological evaluation of mixed dementia. Jellinger, K.A., Attems, J. J. Neurol. Sci. (2007) [Pubmed]
  33. 5th International Congress on the Improvement of the Quality of Life on Dementia, Parkinson's disease, Epilepsy, Multiple Sclerosis and Muscular Disorders. Jellinger, K.A. Expert. Rev. Neurother (2007) [Pubmed]
  34. Predictors of survival in dementia with lewy bodies and Parkinson dementia. Jellinger, K.A., Wenning, G.K., Seppi, K. Neurodegener. Dis (2007) [Pubmed]
  35. The enigma of mixed dementia. Jellinger, K.A. Alzheimer's & Dementia : J. Alzheimer's Association (2007) [Pubmed]
  36. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism. Jellinger, K.A., Attems, J. Acta Neurol. Scand. (2006) [Pubmed]
  37. A short history of neurosciences in Austria. Jellinger, K.A. J. Neural. Transm (2006) [Pubmed]
  38. The morphological basis of mental dysfunction in Parkinson's disease. Jellinger, K.A. J. Neurol. Sci. (2006) [Pubmed]
  39. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?. Jellinger, K.A., Attems, J. Acta Neuropathol. (2006) [Pubmed]
  40. Clinicopathological analysis of dementia disorders in the elderly--an update. Jellinger, K.A. J. Alzheimers Dis. (2006) [Pubmed]
  41. Highlights in the history of neurosciences in Austria--review. Jellinger, K.A. Clin. Neuropathol. (2006) [Pubmed]
  42. Challenges in neuronal apoptosis. Jellinger, K.A. Current. Alzheimer. Research (2006) [Pubmed]
  43. Alzheimer 100--highlights in the history of Alzheimer research. Jellinger, K.A. J. Neural. Transm (2006) [Pubmed]
  44. Commentary on "Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples". Jellinger, K.A. Alzheimer's & Dementia : J. Alzheimer's Association (2006) [Pubmed]
  45. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. Jellinger, K.A., Attems, J. J. Neurol. Sci. (2005) [Pubmed]
  46. Understanding the pathology of vascular cognitive impairment. Jellinger, K.A. J. Neurol. Sci. (2005) [Pubmed]
  47. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Jellinger, K.A., Seppi, K., Wenning, G.K. Mov. Disord. (2005) [Pubmed]
  48. Lewy body-related alpha-synucleinopathy in the aged human brain. Jellinger, K.A. J. Neural. Transm (2004) [Pubmed]
  49. Head injury and dementia. Jellinger, K.A. Curr. Opin. Neurol. (2004) [Pubmed]
  50. Pathology and pathophysiology of vascular cognitive impairment. A critical update. Jellinger, K.A. Panminerva. Med (2004) [Pubmed]
  51. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Jellinger, K.A., Attems, J. Acta Neuropathol. (2003) [Pubmed]
  52. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Jellinger, K.A. Acta Neuropathol. (2003) [Pubmed]
  53. Rett Syndrome -- an update. Jellinger, K.A. J. Neural. Transm (2003) [Pubmed]
  54. Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study. Jellinger, K.A. J. Neural. Transm (2003) [Pubmed]
  55. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study. Jellinger, K.A. Acta Neuropathol. (2003) [Pubmed]
  56. General aspects of neurodegeneration. Jellinger, K.A. J. Neural Transm. Suppl. (2003) [Pubmed]
  57. Neuropathological spectrum of synucleinopathies. Jellinger, K.A. Mov. Disord. (2003) [Pubmed]
  58. The impact of cerebrovascular lesions in Alzheimer disease--a comparative autopsy study. Jellinger, K.A., Mitter-Ferstl, E. J. Neurol. (2003) [Pubmed]
  59. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. Jellinger, K.A., Seppi, K., Wenning, G.K., Poewe, W. J. Neural. Transm (2002) [Pubmed]
  60. Alzheimer disease and cerebrovascular pathology: an update. Jellinger, K.A. J. Neural. Transm (2002) [Pubmed]
  61. The pathology of ischemic-vascular dementia: an update. Jellinger, K.A. J. Neurol. Sci. (2002) [Pubmed]
  62. Vascular-ischemic dementia: an update. Jellinger, K.A. J. Neural Transm. Suppl. (2002) [Pubmed]
  63. Recent developments in the pathology of Parkinson's disease. Jellinger, K.A. J. Neural Transm. Suppl. (2002) [Pubmed]
  64. Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. Rösler, N., Wichart, I., Jellinger, K.A. J. Neural. Transm (2001) [Pubmed]
  65. Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. Jellinger, K.A., Paulus, W., Wrocklage, C., Litvan, I. BMC. Neurol (2001) [Pubmed]
  66. Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. Jellinger, K.A., Paulus, W., Wrocklage, C., Litvan, I. Eur. J. Neurol. (2001) [Pubmed]
  67. Cell death mechanisms in neurodegeneration. Jellinger, K.A. J. Cell. Mol. Med. (2001) [Pubmed]
  68. Cell death mechanisms in Parkinson's disease. Jellinger, K.A. J. Neural. Transm (2000) [Pubmed]
  69. Mechanisms of cell death in neurodegenerative disorders. Jellinger, K.A., Stadelmann, C. J. Neural Transm. Suppl. (2000) [Pubmed]
  70. Morphological substrates of mental dysfunction in Lewy body disease: an update. Jellinger, K.A. J. Neural Transm. Suppl. (2000) [Pubmed]
  71. Neuropathology and general autopsy findings in AIDS during the last 15 years. Jellinger, K.A., Setinek, U., Drlicek, M., Böhm, G., Steurer, A., Lintner, F. Acta Neuropathol. (2000) [Pubmed]
  72. The enigma of cell death in neurodegenerative disorders. Jellinger, K.A., Stadelmann, C.H. J. Neural Transm. Suppl. (2000) [Pubmed]
  73. The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease. Jellinger, K.A. Drugs. Aging (1999) [Pubmed]
  74. What is new in degenerative dementia disorders?. Jellinger, K.A. Wien. Klin. Wochenschr. (1999) [Pubmed]
  75. Parkinson's Disease--13th International congress. 24-28 July 1999, Vancouver, Canada. Jellinger, K.A. IDrugs (1999) [Pubmed]
  76. No increased incidence of Alzheimer's disease in elderly schizophrenics. Jellinger, K.A., Gabriel, E. Acta Neuropathol. (1999) [Pubmed]
  77. Senile dementia with tangles (tangle predominant form of senile dementia). Jellinger, K.A., Bancher, C. Brain Pathol. (1998) [Pubmed]
  78. Dementia with grains (argyrophilic grain disease). Jellinger, K.A. Brain Pathol. (1998) [Pubmed]
WikiGenes - Universities